Lcl161 enhances expansion and survival of engineered anti-tumor t cells but is restricted by death signaling

HIGHLIGHTS

• who: April and collaborators from the United States University of Cambridge, United Kingdom have published the paper: LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling, in the Journal: (JOURNAL)
• how: A simple regression was calculated to determine linear fit. Flow cytometry Microbead antigen loading Flow cytometry data were collected with BD LSR II (V/B/R or V/B/YG/R laser configuration) BD LSR Fortessa (V/B/R laser configuration) or Beckman Coulter CytoFLEX LX (NUV/V/YG/ B/R laser configuration) and analyzed using . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.